Hemicrania continua (HC) is an uncommon and under-recognized primary headache disorder characterized by a strictly unilateral continuous headache of moderate intensity with possible exacerbations and associated with ipsilateral autonomic features. HC has generally a prompt and enduring response to indomethacin although 25% to 50% of treated patients develop gastrointestinal side effects.
title = "Prophylaxis of hemicrania continua: two new cases effectively treated with topiramate.",
abstract = "Hemicrania continua (HC) is an uncommon and under-recognized primary headache disorder characterized by a strictly unilateral continuous headache of moderate intensity with possible exacerbations and associated with ipsilateral autonomic features. HC has generally a prompt and enduring response to indomethacin although 25% to 50% of treated patients develop gastrointestinal side effects.",
author = "Brigida Fierro and Giuseppe Cosentino and Filippo Brighina",
year = "2007",
language = "English",
volume = "47",
pages = "441--443",
journal = "Headache",
issn = "0017-8748",
publisher = "Wiley-Blackwell",
}
TY - JOUR
T1 - Prophylaxis of hemicrania continua: two new cases effectively treated with topiramate.
AU - Fierro, Brigida
AU - Cosentino, Giuseppe
AU - Brighina, Filippo
PY - 2007
Y1 - 2007
N2 - Hemicrania continua (HC) is an uncommon and under-recognized primary headache disorder characterized by a strictly unilateral continuous headache of moderate intensity with possible exacerbations and associated with ipsilateral autonomic features. HC has generally a prompt and enduring response to indomethacin although 25% to 50% of treated patients develop gastrointestinal side effects.
AB - Hemicrania continua (HC) is an uncommon and under-recognized primary headache disorder characterized by a strictly unilateral continuous headache of moderate intensity with possible exacerbations and associated with ipsilateral autonomic features. HC has generally a prompt and enduring response to indomethacin although 25% to 50% of treated patients develop gastrointestinal side effects.